Neurovascular Devices Market By Product Type (Cerebral Embolization and Aneurysm Coiling Devices {Embolic coils, Flow diversion devices, Liquid embolic agents}, Cerebral Angioplasty and Stenting Systems {Carotid artery stents, Embolic protection systems, Balloon Catheters}, Neurothrombectomy Devices {Clot retrieval devices, Suction devices/aspiration catheters, Vascular snares}, Support Devices {Micro catheters, Micro guidewires}, Trans Radial Access Devices, Other), By Technology (Coiling Technology, Flow Diversion Technology, Aspiration and Stent Retriever Tech, Balloon-Assisted Technologies, Bioactive and Bioresorbable Materials, Other), By Application (Ischemic Stroke, Carotid Artery Stenosis, Cerebral Aneurysm, Arteriovenous Malformations (AVMs) and Fistulas (AVFs), Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Neurology Clinics, Academic & Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Industry Outlook

The Neurovascular Devices market accounted for USD 3.20 Billion in 2024 and is expected to reach USD 6.30 Billion by 2035, growing at a CAGR of around 6.35% between 2025 and 2035. The Neurovascular Devices Market is experiencing rapid growth due to the increasing occurrence of strokes, cerebral aneurysms, and neurovascular disorders among older citizens globally. Medical technology continues to advance, introducing stent retrievers, flow diverters, and liquid embolics into practice, which provide better treatment outcomes and enhance patient success. Strong market expansion appears likely due to increasing patient awareness, improved diagnostic tools, and the rising healthcare infrastructure for stroke treatment, particularly in emerging market countries. The North American healthcare system leads in therapy adoption rates, while the Asia-Pacific region exhibits the highest growth rate, driven by its substantial patient base and increased healthcare funding.

Through the following decade, the market is expected to grow due to supportive regulatory approvals, enhanced R&D efforts, and rising demand for endovascular procedures in preference to open surgeries.

Report Scope:

Market Dynamics

Rising stroke incidence fuels the demand for effective neurovascular intervention solutions globally.

The overall market for neurovascular devices continues to expand because the growing number of worldwide stroke and neurovascular disease cases affect primarily elderly patients. Monthly throughout the globe stroke proves to be among the top two causes of death resulting in approximately 12 million new stroke cases annually as reported by the World Health Organisation. Stroke incidence has increased dramatically because diabetes, high blood pressure, obesity, and inactivity often occur together.

Minimal-invasive stroke treatment procedures need to be implemented to manage the increasing number of stroke incidents by using flow diverters together with embolization coils and stent retrievers. The therapeutic techniques result in improved treatment results through fast and effective therapeutic measures. The growing worldwide dedication of healthcare facilities to establish stroke-ready capabilities and enhance neuro interventional resources will result in substantial increases in neurovascular device market expansion.

Advancements in minimally invasive technologies improve treatment outcomes and recovery rates.

The need for neurovascular devices arose because new minimally invasive surgical technologies enable the treatment of stroke and other cerebrovascular conditions. Medical interventions using next-generation flow diverters together with liquid embolic and stent retrievers provide focused treatments that decrease trauma while shortening hospitalization and treatment durations and reducing recovery time.

Modern equipment components led to enhanced patient satisfaction while enlarging medical applications and boosting medical professional support. Research and development studies resulting in rising regulatory approvals cause the market for enhanced neurovascular devices to grow within existing healthcare networks as well as newly created stroke centers around the world.

High costs of neurovascular procedures limit access in low-income regions.

High costs deactivated the market potential of neurovascular devices particularly in developing nations. The patient population from these regions is unable to obtain expensive medical equipment and treatments because they do not possess sufficient financial resources or medical insurance. The unavailability of effective treatments for stroke or aneurysm conditions due to high costs results in deteriorating health results which further deepen health disparities.

Healthcare institutions in developing nations avoid financing specialized care because the financial burden leads to reduced knowledge about neurovascular treatments and low demand for neurovascular interventions. Clearing up financial barriers remains essential because it both enhances access and delivers fair medical care to all patients.

Growing healthcare investments in Asia-Pacific create emerging market expansion potential.

Expanding healthcare facility infrastructure throughout developing Asia-Pacific areas together with Latin America and Middle East and African regions makes the neurovascular device market highly promising. Advancements in neurovascular treatments remain inaccessible to numerous regions even though population growth and changing life patterns have occurred.

New developments constitute major barriers to the ongoing rise of stroke cases. The industry segment of advanced neurovascular equipment continues to grow rapidly because public and private organizations make major investments in stroke centers and tele-neurology and interventional radiology units. Foreign device manufacturers enter restricted markets through improved care access and better market visibility as well as advantageous regulatory reforms.

R&D in bioresorbable materials opens new frontiers in device development.

The investigation of bioresorbable substances holds major promise for developing medical devices, particularly within the neurovascular device market sphere. The natural breakdown of bioresorbable materials into body materials removes the necessity for later medical procedures to retrieve the device after its suggested usage. This method decreases implant-related problems in the long term yet advances patient safety along with comfort.

Manufacturers develop better products for promoting healing through research that drives the exploration of innovative materials resulting in decreased occurrences of long-term foreign body reactions. Bioabsorbable technology supports two essential healthcare advancements through its properties since it enables minimally invasive procedures and individualized medicine for different medical needs.

Industry Experts Opinion

“Affordability should never come in the way of patients accessing advanced healthcare. The S3V Vascular Technologies has the potential to be a boon for brain stroke patients across income classes and geographies. This also fits in with my belief that our Indigenous engineering compares favorably with the world’s finest,’’

• A M Naik, Chairman Emeritus, L&T.

Segment Analysis

Based on Products, Cerebral Embolization and Aneurysm Coiling Devices maintain the foremost position in the Neurovascular Devices Market as the leading product-type segment. Accompanying healthcare practitioners prefer minimally invasive procedures to address intracranial aneurysms as their prevalence increases thus establishing the top position for this sector. Embolic coils and flow diverters function as safe neurological disorder treatments because they achieve more effective clinical results than standard surgical approaches. The adoption of market solutions by neuro interventional experts rose because long-term technology developments produced hydrogel-coated and 3D-designed coil models which led to better clinical results. The segment leads the market because of substantial clinical proof backed by universal approvals and treatment standards.

Based on Technology in the neurovascular devices market, coiling technology leads the market because it provides broad clinical usage for the treatment of intracranial aneurysms. The procedure serves as a minimal invasion treatment which provides safer options than surgical clipping so interventional neurosurgeons and radiologists follow it as their primary selection. Multiple studies with promising results have convinced medical professionals to approve this technique because it has remained an established clinical practice technique for several years.

Regional Analysis

North America dominates the Neurovascular Devices Market primarily because its healthcare system is well-developed along with its high medical spending and broad understanding of stroke healthcare issues among the population. The United States leads neurovascular device markets because it includes major market companies in addition to its highly specialized surgical facilities built within extensive research-based structures. North American hospitals benefit from technological leadership through continuous FDA applications and positive reimbursement systems which enable stent retriever and flow diverter and liquid embolic device deployment. The high rate of stroke cases reported annually by the CDC as 800,000 incidents across North America sustains demand for better stroke treatment approaches. Asia-Pacific exceeds other markets as the leader for neurovascular devices because of aging populations and rising stroke events together with intensifying awareness of neurointerventional approaches.

The fast market growth patterns in Asia-Pacific territory stem from China and India together with Japan and South Korea. Stroke frequencies within the Chinese healthcare setting continue to increase annually to 2.4 million new cases thus propelling the government to construct stroke centers specifically for rural and semi-urban localities. Through its Ayushman Bharat program, India expands neurology healthcare services for citizens residing in unserved population zones. Enhanced accessibility results from two factors: first, the expansion in the neurosurgery expert workforce of Asia-Pacific, and second, the collaborative partnerships between medical device companies. Furthermore, geographical R&D facilities propel device manufacturing within the region and reduce prices. Medical care in this segment will sustain high growth because of minute surgical procedures along with growing healthcare budgets coupled with improved medical detection systems.

Competitive Landscape

Multiple established medical device corporations along with recent innovation-driven businesses continue their competition within the neurovascular devices market. The leading market participants expand their power bases by dedication to technology innovations combined with strategic business partnerships and streamlined product introduction and regulatory endorsement systems. Research and development commitments allow manufacturing companies to develop innovative medical devices including bioactive coils and improved stents and flow diverters which yield better clinical results and safety benefits to patients.

The market leadership currently belongs to Medtronic plc alongside Stryker Corporation and Johnson & Johnson Cerenovus alongside Penumbra Inc. and MicroVention Inc. as a division of Terumo Company. Market leadership belongs to the firms due to their diverse product offerings and extensive distribution channels combined with their persistent innovations. The medical sector heavily relies on the two famous products of Medtronic and Stryker-called Solitaire™ X and Trevo® retriever-for performing mechanical thrombectomy procedures. Diminishing neurovascular cases drive increased demand for flow diversion products from MicroVention Inc. alongside the growth of aspiration products from Penumbra Inc.

Neurovascular Devices Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2024, Mentice launched NV Connect in November 2024 which forms a medical platform for neurovascular training and treatment planning and rehearsal with the main advantage of enhancing procedure accuracy as well as physician trust levels. The press release of this news is available.
• In January 2023, Penumbra Inc. initiated nationwide US distribution of Lightning Flash during January 2023 following the FDA's approval of its approval.

Frequently Asked Questions (FAQs)